Lymphoid Malignancy Flashcards
What is leukaemia cancers of?
Lymphoid origin
Presentation of leukaemia
Enlarged lymph nodes (lymphadenopathy) OR with extranodal involvement OR with bone marrow involvement Systemic symptoms - weight loss (>10% in 6 months) - fever - night sweats - pruritis - fatigue
What test tells us the type of leukaemia?
Biopsy (lymph node, bone marrow etc)
What test tells us where the leukaemia is?
Clinical exam
imaging (e.g. CT)
What is a broad difference of Hodgkin Lymphoma vs Non-Hodgkin Lymphoma?
Hodgkin = specific disease
Non - Hodgkin = everything else (approx. 50 subtypes)
Lymphoproliferative disorders
Acute lymphoblastic leukaemia (ALL)
Chronic lymphocytic leukaemia (CLL)
Hodgkin Lymphoma
Non-Hodgkin Lymphoma (NHL)
Types of Non-Hodgkin Lymphoma (NHL)
High grade
- diffuse large B cell lymphoma
Low grade
- follicular, marginal zone
What is acute lymphoblastic leukaemia (ALL)?
Neoplastic disorder of lymphoblasts
How is ALL diagnosed?
By > 20% lymphoblasts present in bone marrow
Who does 75% of cases of ALL occur in?
Children < 6 y/o
How much of ALL is B cell lineage?
75-90%
Presentation of ALL
2-3 week history of bone marrow failure +/- raised white cell count or bone/joint pain
Infection
Sweats
Treatment of ALL
Induction chemo to obtain remission Consolidation therapy CNS directed treatment Maintenance therapy for 18 months Allogenic stem cell transplantation (if HIGH RISK) newer therapies - Bispecific T cell engagers - CAR
S/Es of T cell immunotherapy
Cytokine release syndrome
Neurotoxicity
Presentation of cytokine release syndrome
Fever
Hypotension
Dyspnoea
Presentation of neurotoxicity
Confusion with normal conscious level seizure headache focal neurology coma
Poor risk factors for ALL
Increasing age increased WCC immunophenotyped (more primitive forms) Cytogenetics/molecular genetics (t(9;22), t(4;11)) Slow/poor response to treatment
Prognosis of ALL
Adults - complete remission 78-91% - leukaemia free survival a 5 y - 30-35% Children - 5 yr overall survival 90% - Poor risk patients (slow response to induction or Philadelphia positive) 5 yr overall survival 45%
What is the commonest leukaemia worldwide?
Chronic Lymphocytic Leukaemia (CLL)
Which gender gets CLL?
M > F 2:1
Where is CLL rare?
Far east
Presentation of CLL
Often asymptomatic at presentation Bone marrow failure - anaemia - thrombocytopenia Lymphadenopathy Splenomegaly (30%) Fever and sweats (<25%) Hepatomegaly
Diagnosis of CLL
Blood > 5 x10 9/L lymphocytes Bone marrow > 30% lymphocytes Characteristic immunophenotyping - B cell markers (CD 19, 20, 23) - CD5 positive
Associated findings of CLL
Immune Paresis (loss of normal immunoglobulin production) Haemolytic anaemia
Binet staging of CLL
Stage A - < 3 lymph node areas - same survival as matched controls Stage B - 3 or more lymph node areas - survival approx. 8 years Stage C - stage B and anaemia or thrombocytopenia - survival approx. 6 years
Indications for treatment of CLL
Progressive bone marrow failure Massive lymphadenopathy Progressive splenomegaly Lymphocyte doubling time < 6 months or > 50% increase over 2 months Systemic symptoms Autoimmune cytopenias
Treatment of CLL
Often nothing - watch and wait Cytotoxic chemotherapy e.g. fludarabine Monoclonal antibodies e.g. rituximab Novel agents - bruton tyrokinase inhibitor - PI3K inhibitor - BCL-2 inhibitor
Poor prognostic markers of CLL
Advanced disease (Binet Stage B or C)
Atypical lymphocytes morphology
Rapid lymphocyte doubling time < 12 months
CD38 + expression
Loss / mutation p53; dell 11q23 (ATM gene)
Unmutated IgVH gene status
Presentation of lymphoma
Lymphadenopathy / Hepatosplenomegaly
Extranodal disease
B symptoms
Bone marrow involvement
Assessment of staging of lymphoma
Lymph node biopsy
CT scan
Bone marrow aspirate
Trephine
Non-Hodgkin Lymphoma is classified according to what?
Lineage - B or T cell Grade of disease - high grade - low grade Histological features of disease
What is the majority of lineage of Non-Hodgkin’s lymphoma?
B cell in origin
Features of high grade Non-Hodgkin Lymphoma
Aggressive
fast growing
requires combination chemotherapy
Can be cured, but again varies widely
Features of low grade Non-Hodgkin lymphoma
Indolent, often asymptomatic
Responds to chemo but incurable
Medial survival varies by subtype
Specific disease entities of Non-Hodgkin Lymphoma
Diffuse large B cell lymphoma
Follicular lymphoma
What is the commonest subtype of lymphoma?
Diffuse large B cell lymphoma
Is diffuse large B cell non-hodgkins lymphoma high grade or low grade?
High grade
Is follicular lymphoma a high grade or low grade lymphoma?
Low grade